Once‐daily liraglutide (1.2 mg) compared with twice‐daily exenatide (10 μg) in the treatment of type 2 diabetes patients: An indirect treatment comparison meta‐analysis: 2型糖尿病患者每日1次使用利拉鲁肽(1.2 mg)治疗与每日2次使用艾塞那肽(10 μg)治疗的比较:一项间接治疗比较的meta分析
Gespeichert in:
| Veröffentlicht in: | Journal of diabetes 2016-11, Vol.8 (6), p.866-876 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 876 |
|---|---|
| container_issue | 6 |
| container_start_page | 866 |
| container_title | Journal of diabetes |
| container_volume | 8 |
| creator | Twigg, Stephen M. Daja, Mirella M. O’leary, Beth A. Adena, Michael A. |
| description | |
| doi_str_mv | 10.1111/1753-0407.12372 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1111_1753_0407_12372</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1111_1753_0407_12372</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1111_1753_0407_123723</originalsourceid><addsrcrecordid>eNqVkD1OxEAMhUcIJJafmtYlFJudyUAi6BAC0dHQj0zi7Bolk2jGaEnHEbgJF-AMHIKTMAsL2hY3tuz36clPqSOjM5NqZsozO9WnusxMbst8S03-Ntu_sz23u2ovxketi7Io7ES93fmKPl9ea-R2hJYDztsn4Zrg2GQ5dPMTqPpuwEA1LFkWIEveAOiZPK7lGj7ek5w9yIJAAqF05AX6BmQcCHKoGR9IKMKQmHSKF3DpE1BzoEo2kB9Ljr2HjgSTHXpsx8jxQO002EY6XPd9Nbu5vr-6nVahjzFQ44bAHYbRGe1WubjV526VgvvOxf6f-AJO4m-H</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Once‐daily liraglutide (1.2 mg) compared with twice‐daily exenatide (10 μg) in the treatment of type 2 diabetes patients: An indirect treatment comparison meta‐analysis: 2型糖尿病患者每日1次使用利拉鲁肽(1.2 mg)治疗与每日2次使用艾塞那肽(10 μg)治疗的比较:一项间接治疗比较的meta分析</title><source>Access via Wiley Online Library</source><source>Wiley Online Library Open Access</source><creator>Twigg, Stephen M. ; Daja, Mirella M. ; O’leary, Beth A. ; Adena, Michael A.</creator><creatorcontrib>Twigg, Stephen M. ; Daja, Mirella M. ; O’leary, Beth A. ; Adena, Michael A.</creatorcontrib><identifier>ISSN: 1753-0393</identifier><identifier>EISSN: 1753-0407</identifier><identifier>DOI: 10.1111/1753-0407.12372</identifier><language>eng</language><ispartof>Journal of diabetes, 2016-11, Vol.8 (6), p.866-876</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-crossref_primary_10_1111_1753_0407_123723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27925,27926</link.rule.ids></links><search><creatorcontrib>Twigg, Stephen M.</creatorcontrib><creatorcontrib>Daja, Mirella M.</creatorcontrib><creatorcontrib>O’leary, Beth A.</creatorcontrib><creatorcontrib>Adena, Michael A.</creatorcontrib><title>Once‐daily liraglutide (1.2 mg) compared with twice‐daily exenatide (10 μg) in the treatment of type 2 diabetes patients: An indirect treatment comparison meta‐analysis: 2型糖尿病患者每日1次使用利拉鲁肽(1.2 mg)治疗与每日2次使用艾塞那肽(10 μg)治疗的比较:一项间接治疗比较的meta分析</title><title>Journal of diabetes</title><issn>1753-0393</issn><issn>1753-0407</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqVkD1OxEAMhUcIJJafmtYlFJudyUAi6BAC0dHQj0zi7Bolk2jGaEnHEbgJF-AMHIKTMAsL2hY3tuz36clPqSOjM5NqZsozO9WnusxMbst8S03-Ntu_sz23u2ovxketi7Io7ES93fmKPl9ea-R2hJYDztsn4Zrg2GQ5dPMTqPpuwEA1LFkWIEveAOiZPK7lGj7ek5w9yIJAAqF05AX6BmQcCHKoGR9IKMKQmHSKF3DpE1BzoEo2kB9Ljr2HjgSTHXpsx8jxQO002EY6XPd9Nbu5vr-6nVahjzFQ44bAHYbRGe1WubjV526VgvvOxf6f-AJO4m-H</recordid><startdate>201611</startdate><enddate>201611</enddate><creator>Twigg, Stephen M.</creator><creator>Daja, Mirella M.</creator><creator>O’leary, Beth A.</creator><creator>Adena, Michael A.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201611</creationdate><title>Once‐daily liraglutide (1.2 mg) compared with twice‐daily exenatide (10 μg) in the treatment of type 2 diabetes patients: An indirect treatment comparison meta‐analysis</title><author>Twigg, Stephen M. ; Daja, Mirella M. ; O’leary, Beth A. ; Adena, Michael A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1111_1753_0407_123723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Twigg, Stephen M.</creatorcontrib><creatorcontrib>Daja, Mirella M.</creatorcontrib><creatorcontrib>O’leary, Beth A.</creatorcontrib><creatorcontrib>Adena, Michael A.</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of diabetes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Twigg, Stephen M.</au><au>Daja, Mirella M.</au><au>O’leary, Beth A.</au><au>Adena, Michael A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Once‐daily liraglutide (1.2 mg) compared with twice‐daily exenatide (10 μg) in the treatment of type 2 diabetes patients: An indirect treatment comparison meta‐analysis: 2型糖尿病患者每日1次使用利拉鲁肽(1.2 mg)治疗与每日2次使用艾塞那肽(10 μg)治疗的比较:一项间接治疗比较的meta分析</atitle><jtitle>Journal of diabetes</jtitle><date>2016-11</date><risdate>2016</risdate><volume>8</volume><issue>6</issue><spage>866</spage><epage>876</epage><pages>866-876</pages><issn>1753-0393</issn><eissn>1753-0407</eissn><doi>10.1111/1753-0407.12372</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1753-0393 |
| ispartof | Journal of diabetes, 2016-11, Vol.8 (6), p.866-876 |
| issn | 1753-0393 1753-0407 |
| language | eng |
| recordid | cdi_crossref_primary_10_1111_1753_0407_12372 |
| source | Access via Wiley Online Library; Wiley Online Library Open Access |
| title | Once‐daily liraglutide (1.2 mg) compared with twice‐daily exenatide (10 μg) in the treatment of type 2 diabetes patients: An indirect treatment comparison meta‐analysis: 2型糖尿病患者每日1次使用利拉鲁肽(1.2 mg)治疗与每日2次使用艾塞那肽(10 μg)治疗的比较:一项间接治疗比较的meta分析 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T13%3A42%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Once%E2%80%90daily%20liraglutide%20(1.2%20mg)%20compared%20with%20twice%E2%80%90daily%20exenatide%20(10%20%CE%BCg)%20in%20the%20treatment%20of%20type%202%20diabetes%20patients:%20An%20indirect%20treatment%20comparison%20meta%E2%80%90analysis:%202%E5%9E%8B%E7%B3%96%E5%B0%BF%E7%97%85%E6%82%A3%E8%80%85%E6%AF%8F%E6%97%A51%E6%AC%A1%E4%BD%BF%E7%94%A8%E5%88%A9%E6%8B%89%E9%B2%81%E8%82%BD(1.2%20mg)%E6%B2%BB%E7%96%97%E4%B8%8E%E6%AF%8F%E6%97%A52%E6%AC%A1%E4%BD%BF%E7%94%A8%E8%89%BE%E5%A1%9E%E9%82%A3%E8%82%BD(10%20%CE%BCg)%E6%B2%BB%E7%96%97%E7%9A%84%E6%AF%94%E8%BE%83:%E4%B8%80%E9%A1%B9%E9%97%B4%E6%8E%A5%E6%B2%BB%E7%96%97%E6%AF%94%E8%BE%83%E7%9A%84meta%E5%88%86%E6%9E%90&rft.jtitle=Journal%20of%20diabetes&rft.au=Twigg,%20Stephen%20M.&rft.date=2016-11&rft.volume=8&rft.issue=6&rft.spage=866&rft.epage=876&rft.pages=866-876&rft.issn=1753-0393&rft.eissn=1753-0407&rft_id=info:doi/10.1111/1753-0407.12372&rft_dat=%3Ccrossref%3E10_1111_1753_0407_12372%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |